Mesa Laboratories, Inc. MLAB
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 75.32% | -40.32% | 41.86% | 316.59% | -27.77% |
| Total Depreciation and Amortization | -4.92% | -5.24% | -23.30% | 3.97% | -3.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -20.22% | 490.18% | 224.35% | -54.16% | 199.94% |
| Change in Net Operating Assets | -84.84% | 136.79% | -59.45% | 25.85% | 9.31% |
| Cash from Operations | -50.18% | 678.45% | 10.24% | 3.45% | 55.99% |
| Capital Expenditure | 64.56% | 44.60% | 44.91% | 9.96% | 38.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 64.56% | 44.60% | 58.59% | 9.96% | 38.93% |
| Total Debt Issued | -100.00% | -4.76% | -- | -- | -- |
| Total Debt Repaid | 88.97% | -150.82% | 18.12% | 7.96% | -1,290.84% |
| Issuance of Common Stock | -9.71% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 9.71% | -19.62% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.81% | -1.26% | -1.61% | -1.73% | -1.85% |
| Other Financing Activities | 40.43% | -- | 1.75% | -1,170.00% | -429.32% |
| Cash from Financing | -56.21% | -24.58% | 2.68% | 4.88% | 8.44% |
| Foreign Exchange rate Adjustments | 313.46% | -94.14% | -81.44% | 177.07% | -110.48% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -878.18% | 162.35% | 43.69% | 29.22% | 79.27% |